Valuation: OraSure Technologies, Inc.

Market Cap 272M 240M 227M 206M 386M 26.15B 388M 2.71B 1.05B 13.34B 1.02B 1B 42.88B P/E 2026 *
-5.98x
P/E 2027 * -4.88x
Enterprise Value 272M 240M 227M 206M 386M 26.15B 388M 2.71B 1.05B 13.34B 1.02B 1B 42.88B EV / Sales 2026 *
2.23x
EV / Sales 2027 * 2.05x
Free-Float
93.52%
Yield 2026 *
-
Yield 2027 * -
1 day+0.51%
1 week+7.05%
Current month+10.03%
1 month+9.72%
3 months-11.43%
6 months+31.67%
Current year+63.22%
1 week 3.78
Extreme 3.7801
4.12
1 month 3.14
Extreme 3.145
4.12
Current year 2.33
Extreme 2.33
4.58
1 year 2.08
Extreme 2.08
4.58
3 years 2.08
Extreme 2.08
8.45
5 years 2.08
Extreme 2.08
11.89
10 years 2.08
Extreme 2.08
23.01
Manager TitleAgeSince
Chief Executive Officer 52 2022-06-03
Director of Finance/CFO 54 2022-08-07
Chief Tech/Sci/R&D Officer - 2024-11-30
Director TitleAgeSince
Director/Board Member 59 2020-05-31
Director/Board Member 66 2021-11-07
Director/Board Member 52 2022-06-03
Date Insider Type Main position Quantity % Market Cap. Importance
9/6/26 Tax

Chairman

-5,116 0.0074%
6/3/26 Free

Director

46,106 0.0670%
6/3/26 Free

Director

46,106 0.0670%
Change 5-day change 1-year change 3-year change Capi.($)
+0.51%+7.05%+23.44%-34.28% 271M
-0.31%-1.94%-24.39%+2.91% 175B
+0.97%-2.45%-5.01%+13.74% 113B
-1.01%-4.01%-1.04%+66.14% 58.57B
+0.01%+1.73%-0.42%-30.03% 50.07B
-0.43%+0.97%+14.93%+52.46% 49.92B
+0.07%-2.79%+29.18%-9.20% 32.69B
+1.07%+9.73% - - 30.44B
+1.41%+3.83%+43.64%-0.90% 26.07B
+1.98%+7.44%+26.26%-1.90% 23.55B
Average +0.43%+2.42%+11.84%+6.55% 56.02B
Weighted average by Cap. +0.17%-0.23%-2.76%+12.61%

Financials

2026 *2027 *
Net sales 122M 107M 102M 92.11M 173M 11.72B 174M 1.22B 470M 5.98B 458M 449M 19.22B 133M 117M 111M 100M 189M 12.79B 190M 1.33B 512M 6.52B 500M 489M 20.97B
Net income -46.2M -40.63M -38.42M -34.85M -65.45M -4.43B -65.83M -460M -178M -2.26B -173M -170M -7.27B -57.65M -50.71M -47.95M -43.49M -81.68M -5.53B -82.15M -574M -222M -2.82B -216M -212M -9.07B
Net Debt - -
Logo OraSure Technologies, Inc.
OraSure Technologies, Inc. transforms health through actionable insight and decentralizes diagnostics to connect people to healthcare wherever they are. The Company, together with its wholly owned subsidiaries, DNA Genotek Inc. and Sherlock Biosciences, Inc., is engaged in the development, manufacture, and distribution of rapid diagnostic tests and sample collection and stabilization devices designed to discover and detect critical medical conditions. Its products and services include OraQuick ADVANCE Rapid HIV 1/2 Antibody Test, OraQuick HIV Self-Test, Diagnostics Direct Syphilis Health Check, OraQuick Ebola Rapid Antigen Test, InteliSwab COVID-19 Rapid Test Pro, and SickleSCAN Test, among others. Its portfolio of products is sold globally to clinical laboratories, hospitals, physician’s offices, clinics, public health and community-based organizations, research institutions, government agencies, pharmaceutical companies, and direct consumers.
Employees
500
Date Price Change Volume
26-09-28 US$3.950 +0.51% 848,227
26-09-25 US$3.930 0.00% 474,643
26-09-24 US$3.930 -1.50% 693,262
26-09-23 US$3.990 0.00% 383,927
26-09-22 US$3.990 +8.13% 686,303
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
3.950USD
Average target price
4.000USD
Spread / Average Target
+1.27%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. OSUR Stock